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Summary
In many clinical trials to evaluate treatment e cacy it is believed that there may exist
latent treatment eectiveness lag times after which medical treatment procedure or chemi
cal compound would be in full eect In this article semiparametric regression models are
proposed and studied to estimate the treatment eect accounting for such latent lag times
The new models take advantage of the invariance property of the additive hazards model in
marginalizing over random eects so parameters in the models are easy to be estimated and
interpreted while the exibility without specifying baseline hazard function is kept Monte
Carlo simulation studies demonstrate the appropriateness of the proposed semiparametric
estimation procedure Data collected in the actual randomized clinical trial which evalu
ates the eectiveness of biodegradable carmustine polymers for treatment of recurrent brain
tumors are analyzed
Some key words Change Point Clinical trials Cure models Mixture models Random
eects Semiparametric model Survival data

 Introduction
In comparative randomised clinical trials e cacy of a new treatment eg a new drug or
medical procedure is often assessed by comparing collected survival data As expected not
all proposed treatments are always taking eect as soon as their initiation In fact many
treatments are observed to have slow onset of action after their initiation such as in P	erez
et al 
 to assess the e cacy of an antidepressant treatment For such phenomenon
of slow onset of action researchers often believe that there may exist a socalled treatment
eectiveness lag time before the treatment becomes fully eective 
Wu Fisher  DeMets
 Gail  Lakatos  Zucker  Lakatos  A treatment eectiveness lag time
is the time for a biological subject to fully respond to medical procedures or compounds It
is usually not observable although certain biomarkers can be used to articially dene the
termination of treatment eectiveness lag time If the treatment eectiveness lag times are
ignored the assumptions of the widelyused proportional hazards model 
Cox  with
constant proportionality are often inappropriate and hence not able to correctly accommo
date the observation of slow onset of action unless some ad hoc timedependent structure is
included
Although the existence of treatment eectiveness lag time was recognized in most of
previous research in developing appropriate statistical methodologies researchers used the
notion of a common xed treatment eectiveness lag time for every individual or tried to
nd ad hoc timedependent lag functions for the proportional hazards model for instance
in Self et al 
 and Zucker  Lakatos 
 But due to the heterogeneity among
the biological subjects such as unobservable dierent genotypes the treatment eectiveness
lag times could apparently vary individualbyindividual In addition since prior knowledge
about the lag is often rarely available an accurate lag function is usually unknown and

di cult to be determined
To account for the latent treatment eectiveness lag time and its heterogeneity among
individuals an unobservable random variable U  say is introduced in this article to rep
resent such lag time which is treated as a random eect In addition since some of the
treatment eectiveness lag times are too long to allow the full onset of action a mixture
cure model 
Farewell  Gray  Tsiatis  Laska  Meisner  will be adapted
for U  Furthermore to identify the subjectdependent proportion of longterm treatment
eectiveness lag times appropriate regression models will be incorporated into the mixture
cure model
One straightforward approach to estimate the treatment eect accounting for the latent
U is through the proportional hazards model For a specic example given a treatment
eectiveness lag time U  u    the relative hazards ratio can be assumed as  before u
and  after u This is in fact the simplest version of the proportional hazards model with
change point as random eect 
Nguyen Rogers  Walker  Basu Gosh  Joshi 
Although it carries simple form and straightforward interpretation conditioning on the ran
dom eect its marginalized version over the random eect does not own clean multiplicative
form any longer This leads to some serious consequences such as numerical and theoretical
di culties in inference procedures and awkward interpretation in parameters as pointed
out in Lin  Ying 

Instead of the multiplicative proportional hazards model we will propose and study the
change point hazards models with additive random eects to determine the covariate eect
The remainder of this article is organized as follows In x we will present the mixture
model The semiparametric inference procedures and its asymptotic properties are studied
in x Numerical studies are demonstrated in x Some concluding remarks and discussion

are in x Mathematical proofs are collected in Appendices
 The mixture model
Suppose that there are n independent participants in the study For i        n the
failure time and censoring time for individual i are T
i
and C
i
 respectively and U
i
is the
latent treatment eectiveness lag time ie after which the treatment is fully eective The
actual observed data consist of the triplets of 
X
i

i
 Z
i
 Here X
i
 min
T
i
 C
i
 is the
survival time and

i
 I
T
i
  C
i
 
 
 if T
i
  C
i
 otherwise
is the censoring indicator where I
 is the indicator function taking the value of  if the
condition is satised and  otherwise Let superscript T denote the transpose of vector or
matrix and Z
i

t  
W
T
i

t R
T
i

t
T
be the pvector covariate In particular to estimate
a treatment eect such as in a twoarm randomised clinical trial W
i
can be the treatment
indicator being  if the participant is in the treatment group and  otherwise and R
i

t is
the concomitant risk factors or confounding variables for which the treatment eect needs
to be adjusted such as demographic variables or socialeconomic status In addition we
assume that 
T
i
 C
i
 are independent conditional on Z
i

  Distribution of treatment eectiveness lag times
In practice it is noticeable that there exists possibility with which a portion of population
may never respond to the treatment For example when the treatment dosage does not
meet the participants minimal threshold for response the treatment may never be able to
take full eect In this case the treatment eectiveness lag is considered as longterm
Or when the treatment eectiveness lag time is relatively long enough to exceed certain

predetermined time point u
 
 eg  weeks in antidepressant therapy trials 
P	erez et al
 the treatment eectiveness lag time is also considered as longterm Otherwise
the treatment eectiveness lag time subject to early full treatment response is called short
term
Denote Y
i
the indicator of shortterm treatment eectiveness lag time for the ith partic
ipant ie
Y
i

 
 if ith treatment eectiveness lag time is shortterm
 if ith treatment eectiveness lag time is longterm
Furthermore let

F
 

t      F
 

t   be the conditional survival function for Y
i
  i 
      n Then the treatment eectiveness lag time U
i
s survival function

G
i

t  G
i

t
t   is assumed of the cure mixture model 
Farewell 

G
i

t  PrfY
i
 g  PrfU
i
 tjY
i
 g  PrfY
i
 g
 p
i

F
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 
  
  p
i
 

for i        n where p
i
   There are varieties of choices for F 
t   for example
distributions of Exponential Weibull and Gamma
From model 
 it seems in form that G
i

t is not a rigorously dened distribution
function in probability theory whenever p
i
  However it implicitly carries the message
that a treatment eectiveness lag time can be longterm or even innite which exactly
describes the possible scenarios discussed above If necessary to make G
i
more statistically
concrete for example an articial truncation time u
 
 say can be chosen Then the form
of

G
i

t does not change when    t   u
 
but is  when t   u
 

Laska  Meisner 
Tamura Faries  Feng  Nevertheless whether or not choosing a truncation time
should not undermine the development of our proposed method in this article as seen in the
later development

In model 
 p
i
is the probability of the ith participant having shortterm treatment
eectiveness lag time The larger the magnitude of p
i
 the easier the treatment to be fully
eective within a reasonable time range It can also be linked to the corresponding covari
ate Z
i
through appropriate regression models For example the logistic regression models

Farewell  can be used
log
p
i


 

  p
i


 

 
T
 
Z
i

 

Other choices include probit loglog and complementary loglog regression models 
McCul
lagh  Nelder  p 
   Additive hazards models with latent lag time
Denote 
 as the hazard function for the failure time T  We rst use the following model
to determine the covariate eect with the treatment eectiveness lag time
ftjZ
i

t U
i
 
 
g  
 
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 
R
i
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  t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T
is pvector parameter and 
 

t an unknown baseline hazard function
In model 
 conditional on the treatment eectiveness lag time U
i
 the hazard function
of Z
i

t is 
 

t  	
T
 
R
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t before U
i
and 
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t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t after Therefore the
parameter 
 
characterizes the full eect of W
i

t after the treatment eectiveness lag time
which is often of the most interest eg when W
i

t is the treatment indicator
Model 
 is a change point model which generalizes the notion of xed treatment ef
fectiveness lag time in Zucker  Lakatos 
 by introducing heterogeneous treatment
eectiveness lag time U
i
s This reects the truth that dierent individuals may have dif
ferent paces and hence dierent treatment eectiveness lag times Jointly model 
 and

 determine both the probability with which the treatment eect is fully eective within a
reasonable time range and the magnitude of full treatment eect

Model 
 is also an additive hazards model with random eects As argued in Breslow
 Day 
 p   p  and Lin  Ying 
 p  an additive
hazards model is able to provide sound interpretation in clinical studies And more impor
tantly it yields a much simpler marginal model after the random eects are integrated As
shown in Appendix  the marginalized model 
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Assume that R
i

t andW
i

t are bounded Furthermore if there exists an i
 
 f      ng
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 
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Here the additional assumption of PrfU
i
 
  T
i
 
g    is an identiablity condition to
secure the estimability of parameter 
 
and the above properties Otherwise EI
U
i
 
T
i

T
 
W
i

t   for any i and hence 
 
is not estimable This essentially requires that the
treatment eectiveness lag time is not always longer than the failure time for every individual
in study
In fact H
t
 
 

 
 corresponds to the lag function the researchers have been looking
for It is also of interest that H
t
 
 

 
 owns similar properties of cumulative distribution
function 
CDF When W 
t   H
t is exactly the distribution function of G although

its eect on the hazard function is nullied by zero W 
t In x we will demonstrate what
H
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 
 

 
 may appear to be by studying some special H
t
 
 

 
s
In general the identiability can be critical for models with arbitrary random eects
This usually does not impose serious challenges upon model 
 as seen in the following
theorem
Theorem  If W
i

t and the parameter space B are bounded  then model 	
 is identiable
if and only if 
 in G is identiable
To prove the above theorem it is su cient to show that for two treatment eectiveness
lag time distribution functions of G

and G

 they are equal almost everywhere if
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which is straighforward to be established under the assumed conditions
 Inference Procedures and Asymptotic Properties
In this section we present a semiparametric estimation procedure by fully utilizing the
unaltered additive structure in model 

Let N
i
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X
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 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 Therefore similar to the partial score equations

for the proportional hazards model 
Fleming  Harrington  the following estimating
equations can be used to estimate 
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where Q
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 is a measurable weight function with respect to F
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 which converges uni
formly to a deterministic function of q
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Although the baseline hazard function is unknown in 
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as in Lin and Ying 
 Thus we can use the following equations to estimate the param
eters of interest
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Denote the lefthand side of equation 
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 Some algebraic manipulation shows
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To study the asymptotic properties of solutions by solving "
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Proof  See Appendix 
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Proof See Appendix 
In practice to make inference about the estimates of parameters it is natural to use the
empirical estimates of its asymptotic variancecovariance matrix by its consistent estimator
!
D
 


!

!


!
V 

!

!


!
D
 


!

!


T
 where
!
D
 
  n
 
n
X
i
Z
t
 
 
Q
t  
Y
i

tfJ
i

t  


J
t  
gf	
T
R
i

t  
T
W
i

tH
i

t  
g

dt
!
V 

!

!

  n
 
n
X
i
Z
t
 
 
Q
t  
fJ
i

t  


J
t  
g

dN
i

t
Furthermore replacing the parameters of 
 
 with 

!

!

 in 
 leads to a natural estima
tor of the cumulative baseline hazard function As shown in Appendix  n

f
!
 
 

t
!

!


 
 

tg converges weakly to a zeromean Gaussian process with covariance function of #
t

 t


which is the limit of
Z
mint

t


 
n
P
n
i
Y
i

t
P
n
i
dN
i

t
P
n
i
Y
i

t
 K
T


t

D
 
V 
D
 

T
K


t

K
T


t

D
 
K


t

K
T


t

D
 
K


t


where
K


t 
 
 

 
 
Z
t
 

n
X
i
Y
i

sf	
T
 
R
i

s  
T
 
W
i

sH
i

s 
 
 

 
g


n
X
i
Y
i

s

 
ds
K


t 
 
 

 
 
Z
t
 

n
X
i
Y
i

sf	
T
 
R
i

s  
T
 
W
i

sH
i

s 
 
 

 
gJ
i

s 
 
 

 


n
X
i
Y
i

s



n
X
i
Y
i

sf	
T
 
R
i

s  
T
 
W
i

sH
i

s 
 
 

 
g

n
X
i
Y
i

sJ
i

s 
 
 

 




n
X
i
Y
i

s

 
ds
Although the proposed estimating equations can be viewed as parallel to the partial
score equations for the proportional hazards model they are still ad hoc However by the

techniques in Lai  Ying 
 and Lin  Ying 
 we can compute the semiparametric
e ciency bound for the family of parametric submodels as
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However it is di cult to use "
opt
in practice because the estimating functions themselves
involve the baseline hazard function Although adaptive procedures using special techniques
such as samplesplitting in Lin  Ying 
 are available the estimation of 
 
always
imposes an imminent challenge especially when sample size is small
To practically implement the optimal estimating functions similar versions can be used
instead for convenience For example one choice suggested in Lin  Ying 
  is to
use "
opt
without including f
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Apparently when the ignored term does not vary much from a constant then "

should not
lose much e ciency

 Numerical Studies
 Examples of Lag Function H t  

 


As proposed in section  the distribution of G is a mixture cure distribution In this
section we select some special Gs to demonstrate their corresponding lag functions
As seen in the denition of G

F
 

t is in fact the conditional probability that the treat
ment eectiveness lag time occurs after time t for shortterm treatment eectiveness lag
times One simple example is that let F
 

t be Exponential with survival function of
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as seen in Appendix 
In addition if a truncation time is preferable the truncated survival distribution of
Exponential can be used 
Gray  Tsiatis  Laska  Meisner  That is we choose
the truncated exponential distribution of form
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when    t  u
 
and  otherwise Apparently when u
 
goes to  H
t
 
 

 
 has limit as
in 

In addition letW
i

t   
 
  and 
 
    Fig  displays the lag functions
when u
 
  As shown in Figure  since there is no truncation time for the treatment
eectiveness lag times the nal lag functions are smooth When p

 
   ie % short
term treatment eectiveness lag times then marginally the treatment will eventually reaches
the full eect in long run But if there is any proportion of longterm treatment eectiveness
lag times then the full eect is not reachable but instead the treatment eect is washed
out in long run although it may have some eect for early period of time
Figure  about here
Figure  displays the lag functions when u
 
  Since almost all the treatment eective
ness lag times are assumed to happen before u
 
 it is not surprising to see similar patterns as
in Fig  before u
 
 In practice since u
 
often serves as the termination of data collection
we should not be able to observe anything informative after u
 
 But as a demonstration we
still show the possible picture from simulation in Fig  after u
 
 As shown in Fig  the
treatment will eventually reaches its full eect if no lag time exists
Figure  about here
Nevertheless as seen in both Figures  and  when 
 
is bigger the treatment eective
ness lag time becomes shorter and then the mode of H tends to be reached earlier which
means the ultimate treatment eect is reached faster
More examples of lag functions obtained from Weibull and Gamma distributions can be
found in Appendix  In addition the derivatives of H with respect to dierent parameters

are given as well
  Simulation Studies
Simulation studies have been conducted to study the performance of estimation procedure
proposed in Section  Two covariates are generated R which is continuous following the
uniform distribution on  andW  which is  or  with equal probability of & mimicking
a treatment indicator The baseline hazards function is chosen to be a Weibull distribution
Lag times are generated according to mixture distribution in 
 with F
 
to be exponential
and p

 
 to be constant Then Failure times are generated according to model 
 with

	
 
 
 
  
  
 and 
 Independent censoring times are generated from exponential
distribution with dierent means to yield two censoring percentages of approximately %
and % Sample sizes are of  and  Estimating functions in 
 will be used for
parameter estimation
Simulation results are listed in Table  For each entry in the table one thousand repli
cates are simulated to compute the bias and empirical coverage probability Here bias is
dened as the dierence between the sample mean of the estimates over the  simu
lated data sets and its respective true value and % emipirical coverage probability is the
percentage of Waldtype % condence intervals that include the true parameters It is
evident that the estimators are virtually unbiased and the nominal condence intervals for
the parameters have reasonable coverage probabilities
Table  about here

 Real Data Examples
The data to be analyzed are collected from a randomised placebocontrolled trial of the ef
fectiveness of biodegradable carmustine polymers for treatment of recurrent brain malignant
gliomas 
Brem et al  After the recurrent brain tumor was removed a medicated or
placebo polymer was placed to ll in the cavity To reach a higher local drug concentration
the medicated polymers were supposed to gradually release carmustine over a  to  week pe
riod following the placement because it would be more eective than systematic application

Tamargo et al  Brem et al  In  medical centers of this trial  patients
were randomized to either the carmustine polymer treatment group 
 patients or the
placebo polymer group 
 patients Their survival times measured in weeks treatment
assignment and prognostic factors can be found in Piantadosi 
 p  Some
exploratory analysis results can be found in Brem et al 
 and Chen  Wang 

In addition to the treatment indicator 
W  another prognostic covariate of age 
R
is also considered for analysis Results from the proportional hazards model 
tjZ 

 

t exp
Z the additive hazards model 
tjZ  
 

t  Z and the proposed model

 that assumes the exponential F
 
and logistic model for response proportions are listed
in Table  As shown in the table after adjusting for age although the treatment eect
does not appear signicant in either the proportional hazards model or the additive hazards
model it is signicant if the treatment eectiveness lag time is taken into account That
is given the presence of the lag time the treatment will signicantly decrease the hazard
of placebo group by  adjusting for age The estimated average treatment eectiveness
lag time is about  weeks for those who have shortterm lag times Its condence in
terval does not contain  which implies the signicant presence of such lag times In fact
as shown in Figure  of Chen  Wang 
 the two groups are almost indistinguishable

till the th or th week if the eect of age is ignored which also graphically suggests the
potential existence of such lag time Furthermore because of the nonsignicant s the pro
portions of the shortterm responders seem not varying according to treatment assignment
or participants age
Table  about here
 Remarks
A more general mixture model for the treatment eectiveness lag time is

G
t  p

F


t  
  p

F


t 

where

F


t is the survival function for p proportion of treatment eectiveness lag times and

F


t is the survival function for the remaining proportion  p To see this let

F


t  
then model 
 becomes the cure mixture model Furthermore if the hazard function of F

is monotonically increasing we should expect the hazard function of treatment eectiveness
lag time to be initially increasing but decreasing later as the p proportion of shortterm
treatment eectiveness lag times dropping out of the risk set with relatively more longterm
treatment eectiveness lag times left
In the potential presence of treatment eectiveness lag time the socalled intention
totreat principle 
Sheiner  Rubin  may be arguable to be used to estimate the
full treatment eect For example if W 
t is a binary treatment indicator taking the value
of  or  as assumed in model 
 then given the treatment eectiveness lag time U  the
treatment will not be fully eective before U  ie it is still a true control before U 
Therefore marginally he or she should be equivalently counted as a member of treatment
with probability of H
t
 
 

 
 exactly although the participant is physically assigned to the

treatment group As shown in Fig  when 

 
increases as in the Exponential distribution
ie the treatment eectiveness lag time tends to be shorter the treatment reaches its full
eect quicker
In Model 
 the most critical part is the random eects are additive to possibly gain
benet in designing simple inference procedures It is less critical whether or not the xed
eect of R
i

t to be additive or multiplicative Thus another class of change point hazards
models with additive random eects is
ftjZ
i

t U
i
 
 
g  
 
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 I
U
i
  t
T
 
W
i

t 

In contrast to the general additivemultiplicative hazards model in Lin  Ying 
 it is
not to di cult to nd that model 
 is a parallel model but with random eects included
in the additive component Nevertheless the marginalized model 
 should have sameH
i
s
as in 
 It is then straightforward to extend all the inference procedures and asymptotic
results to model 

Although the model proposed in this article has certain prominent advantages there are
some critical issues in actually implementing this model The rst issue is inherited from the
additive hazards model That is the parameter space is restricted by the magnitude of the
baseline hazard function in order to obtain reasonable parameter estimates One solution is to
replace Z with exp
Z but then the interpretation of  becomes cumbersome The second
issue is inherited from the cure mixture model which is the potential identiability problem
with the parameters in the regression model of response proportions and the parameters in
F
 
 As pointed out by Farewell 
 p  the estimates of these parameters here
also tend to have high correlation because of possible overparametrisation of the lag times
This issue would be less critical if there is strong pathological evidence to support the notion
of existence of two heterogeneous population Otherwise only modelling F
 
but ignoring ps

is good enough to detect the potential existence of the lag time estimate its average and
derive a good lag function in practice

Appendix 
Marginalization of Model 	

According to model 
 we know that
 
tjZ
i

t U
i
 
 
 
Z
t
 
f
 

s  	
T
 
R
i

s  I
U
i
  s
T
 
W
i

sgds
  
 

t 
Z
t
 
	
T
 
R
i

sds 
Z
t
 
I
U
i
  s
T
 
W
i

sds
  
 

t 
Z
t
 
	
T
 
R
i

sds  I
U
i
  t
Z
t
U
i

T
 
W
i

sds
and
S
tjZ
i

t U
i
 
 
  exp
 
 
 

t
Z
t
 
	
T
 
R
i

sds I
U
i
  t
Z
t
U
i

T
 
W
i

sds


Therefore the marginal survival function is then
S
tjZ
i

t 
 
 

 

 e
 
 
t 
T
 
R
t
 
R
i
sds
Z

 
e
  
T
 
Iut
R
t
u
W
i
sds
dG
u

 

The marginal hazard function is

tjZ
i

t 
 
 

 
  
d
dt
logS
tjZ
i

t 
 
 

 

 
 

t  	
T
 
R
i

t
d
dt
log
Z

 
e
  
T
 
Iut
R
t
u
W
i
sds
dG
u

 

 
 

t  	
T
 
R
i

t
d
dt
R

 
e
  
T
 
Iut
R
t
u
W
i
sds
dG
u

 

R

 
e
  
T
 
Iut
R
t
u
W
i
sds
dG
u

 

 
 

t  	
T
 
R
i

t 

T
 
W
i

s
R
t
 
e
  
T
 
R
t
u
W
i
sds
dG
u

 

R
T
 
e
  
T
 
R
t
u
W
i
sds
dG
u

 
  G
t

 


Appendix 
Asymptotics
 Weak convergence of n
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martingale process with the regularity conditions of
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The second term on the righthand side in the above equation is an average of mar
tingale integrals therefore it converges in probability to zero With the conditions in
Theorem  it is true that the rst term converges to A Therefore n"
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Therefore the asymptotic normality of estimators are established A straightforward
variance calculation would lead to the results in Theorem 
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 by the Lenglart inequality 
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dersen et al 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 It is also straightforward to see that term 
III is asymptotically
ignorable Therefore by the multivariate martingale central limit theorem then the
asymptotic results of
!
 is established The variance calculation is straightforward
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Examples of lag functions
 Exponential lag time f
t  
 
e
 
 
t
H 
 

 
p

 


 
W
 
 
 

e
 
 
t
 e
  
 
W
 
t

 

 
p

 


 
W
 
 
 

e
 
 
t
 e
  
 
W
 
t

 p

 
e
 
 
u
  p

 


 
H

 
 



 
W
 
p

 



  
 
t 
 
W
 
t


 p

 
 e
  
 
W
 
t
 p

 
e
 t
 
 
 
W
 




  p

 
e
 
 
t
 p

 


e
 
 
t




 
p

 
e
  
 
W
 
t
 p

 
e
 
 
t

 
W
 
 
 
W
 
 p

 

 
W
 
 
 
 
 
p

 


 
H


 
 p

 



 p

 




 
t 
 

 
W
 
t 
 
W
 

 p

 

 
W
 
e
 
 
t

e
 
 
t
 
 p

 

 
W
 
e
  
 
W
 
t
 p

 




 
t 
 

 
W
 
t 
 
W
 

e
 t
 
 
 
W
 





 
p

 
e
  
 
W
 
t
 p

 
e
 
 
t

 
W
 
 
 
W
 
 
 
 p

 

 
W
 
 
 
p

 


 
H

p
 

 
W
 
 
 


e
 
 
t
 e
  
 
W
 
t


 



 
p

 
e
  
 
W
 
t
 p

 
e
 
 
t

 
W
 
 
 
W
 
 
 
 p

 

 
W
 
 
 
p

 


 
 Weibull lag time f
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